The well-established prognostic factors currently used into the management of breast cancer patients include the disease stage as well as the degree of differentiation (tumour grade), the proliferation index, and the hormone receptor status (ER, PR, and, recently, HER2) in primary tumours [35,36]. The gene discussed is NR4A1; the disease is breast carcinoma.